The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 12, 2021
Filed:
Jan. 06, 2020
Applicants:
Cornell University, Ithaca, NY (US);
Ithaca College, Ithaca, NY (US);
Inventors:
Richard Cerione, Ithaca, NY (US);
Kristin Cerione, Ithaca, NY (US);
Clint Stalnecker, Ithaca, NY (US);
Scott Ulrich, Brooktondale, NY (US);
Assignees:
CORNELL UNIVERSITY, Ithaca, NY (US);
ITHACA COLLEGE, Ithaca, NY (US);
Primary Examiner:
Int. Cl.
CPC ...
C07C 211/52 (2006.01); C07C 211/58 (2006.01); C07C 211/59 (2006.01); C07C 217/90 (2006.01); C07C 237/40 (2006.01); C07C 311/21 (2006.01); C07D 207/16 (2006.01); C07D 221/04 (2006.01); C07D 221/06 (2006.01); C07D 221/12 (2006.01); C07D 221/18 (2006.01); C07D 233/61 (2006.01); C07D 277/82 (2006.01); C07D 295/135 (2006.01); C07D 401/10 (2006.01); C12N 9/80 (2006.01); C12N 9/96 (2006.01); C12Q 1/34 (2006.01); C07D 471/04 (2006.01); C07C 311/37 (2006.01); C07C 211/49 (2006.01);
U.S. Cl.
CPC ...
C07D 471/04 (2013.01); C07C 211/49 (2013.01); C07C 211/52 (2013.01); C07C 211/58 (2013.01); C07C 211/59 (2013.01); C07C 217/90 (2013.01); C07C 237/40 (2013.01); C07C 311/21 (2013.01); C07C 311/37 (2013.01); C07D 207/16 (2013.01); C07D 221/04 (2013.01); C07D 221/06 (2013.01); C07D 221/12 (2013.01); C07D 221/18 (2013.01); C07D 233/61 (2013.01); C07D 277/82 (2013.01); C07D 295/135 (2013.01); C07D 401/10 (2013.01); C12N 9/80 (2013.01); C12N 9/96 (2013.01); C12Q 1/34 (2013.01); C12Y 305/01002 (2013.01); G01N 2333/98 (2013.01);
Abstract
The present invention relates generally to glutaminase inhibitors of Formula I, Formula II, or Formula III, as well as pharmaceutical compounds containing them and methods of their use.